Man uses AI to build $1 billion telehealth company, but secret sauce is GLP-1 drug - India Today
Man uses AI to build $1 billion telehealth company, but secret sauce is GLP-1 drug India Today
Could not retrieve the full article text.
Read on GNews AI India →Sign in to highlight and annotate this article
Conversation starters
Daily AI Digest
Get the top 5 AI stories delivered to your inbox every morning.
More about
companybillionindia
Exclusive | OpenAI Buys Tech-Industry Talk Show TBPN - WSJ
Exclusive | OpenAI Buys Tech-Industry Talk Show TBPN WSJ OpenAI Buys Streaming Show ‘TBPN,’ Aiming to Change Narrative on A.I. The New York Times OpenAI is officially a media company, after buying Silicon Valley’s favorite podcast TBPN MarketWatch
Knowledge Map
Connected Articles — Knowledge Graph
This article is connected to other articles through shared AI topics and tags.
More in Products
Exclusive | OpenAI Buys Tech-Industry Talk Show TBPN - WSJ
Exclusive | OpenAI Buys Tech-Industry Talk Show TBPN WSJ OpenAI Buys Streaming Show ‘TBPN,’ Aiming to Change Narrative on A.I. The New York Times OpenAI is officially a media company, after buying Silicon Valley’s favorite podcast TBPN MarketWatch
Looking for arXiv endorser (cs.CL) NLP text classification paper
Hi everyone, I’m looking for an arXiv endorser for the cs.CL category. I’ve published a preprint on Zenodo: “AI-Powered Appeals Processing: Comparative Analysis of Word2Vec+LSTM and BERT for Russian-Language Text Classification” DOI: AI Appeals Processor: A Deep Learning Approach to Automated Classification of Citizen Appeals in Government Services The paper compares Word2Vec+LSTM and BERT-based approaches for classifying citizen appeals in Russian, including experiments with pymorphy2 lemmatization and its effect on model performance. It’s based on a real production system processing 10,000+ documents. This is my first arXiv submission and I don’t have an existing endorser in my network. Endorsement code: SRYHMJ arXiv endorsement page: Log in to arXiv | arXiv e-print repository Any help w
Discussion
Sign in to join the discussion
No comments yet — be the first to share your thoughts!